who cannot take glp 1 GLP-1 Medications: Everything You Need to Know GLP-1 and Anesthesia: Considerations and

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbll T

Within the same period, the dispensed prescriptions within the benefit to incident patients with a preexisting diagnosis of obesity without T2DM increased by 270% (4.0 to 14.6%), and 502% for patients with neither obesity nor T2DM (5.3 to 32.1%), and 515% for patients without any of the included diagnoses (4.2 to 25.7%) (see Table 9 in the Appendix)

10.1523/JNEUROSCI.5749-09.2010 80 RinamanL

GIP also influences fat metabolism, though its effects are complex and context-dependent

Retrieved from Mayo Clinic

10.1007/s00198-014-2845-8 171 MisraM.BredellaM